Jena, Germany

Frank Brunkhorst

USPTO Granted Patents = 1 

 

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2020

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Mind of Frank Brunkhorst

Introduction

Frank Brunkhorst is a distinguished inventor based in Jena, Germany, known for his significant contributions to the field of medicine. With a focus on diagnostic methods, Frank has developed innovative solutions aimed at improving the outcomes for patients suffering from critical conditions such as sepsis.

Latest Patents

Frank Brunkhorst holds a patent titled "Diagnosis of sepsis and systemic inflammatory response syndrome." This groundbreaking invention pertains to a method that aids in the diagnosis, prediction, or risk stratification for mortality and/or disease outcome in subjects suspected of having sepsis. The process involves examining the presence and/or levels of antitrypsin (ATT) and transthyretin (TTR) in biological samples, providing a correlation with increased risks of mortality and poor disease outcomes.

Career Highlights

Frank is affiliated with the Universitätsklinikum Jena, a prominent medical institution where he engages in research and development efforts. His work is vital in enhancing the understanding of sepsis and improving diagnostic accuracy, which ultimately benefits numerous patients worldwide.

Collaborations

Throughout his career, Frank has collaborated with notable colleagues including Michael Kiehntopf and Diana Schmerler. These partnerships contribute to the research environment at Universitätsklinikum Jena, fostering innovation and driving forward the field of medical diagnostics.

Conclusion

In summary, Frank Brunkhorst exemplifies the role of an inventor in the medical field. His patent demonstrates a clear commitment to advancing healthcare through innovative diagnostic methods. With ongoing collaborations and research, Frank continues to make significant contributions that could save lives and improve medical outcomes for patients at risk of sepsis.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…